Laura Rico, PhD
Preclinical Sc.-Reg. Aff. Advisor. Biological & Advanced Therapies specialist.
Founder & CEO of a sc.-regulatory consultancy, in preclinical R&D for Biological & Advanced Therapies (ATMP). Interim CEO and R&D Manager of biotech co. 3 business accelerations certificates (SILO-EOI, AcexHealth And., Incibe-Tetuan V.-Google). 25+ years-experience: Sc. Director of the 1st Spanish cell-th. co. (Cellerix, now Takeda), Precl. R&D Head at the sector's leading public initiative (now "Radytta"). +60 projects promoted, + 50 regulatory documents delivered. Lecturer in university courses and master programs in the field. Participant in various expert committees and working groups.